SCHEMBL12840486

SCHEMBL12840486

COc1ccc(-c2cnc(NC(=O)CC(C)C)c(Cc3ccccc3)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
NPC1 O15118 2/20 0.52
ALDH1A1 P00352 2/20 0.52
TP53 P04637 2/20 0.52
RAB9A P51151 2/20 0.52
MAPT P10636 2/20 0.52
LMNA P02545 1/20 0.52
PRKDC P78527 1/20 0.45
ATR Q13535 1/20 0.45
ADORA1 P30542 2/20 0.45
KDR P35968 3/20 0.43
ADORA3 P0DMS8 1/20 0.43
ADORA2A P29274 1/20 0.43
CDK5 Q00535 1/20 0.42
CDK5R1 Q15078 1/20 0.42
PTPN1 P18031 1/20 0.42
ALOX15 P16050 1/20 0.42
ABL1 P00519 1/20 0.42
YES1 P07947 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12838938 0.91 MAPT (0.51) MAPK1SMN1; SMN2NPC1ALDH1A1TP53
SCHEMBL12838999 0.91 ADORA1 (0.54) SMN1; SMN2NPC1ALDH1A1RAB9AMAPT
SCHEMBL1354211 0.89 ALDH1A1 (0.53) SMN1; SMN2NPC1ALDH1A1TP53RAB9A
SCHEMBL12839398 0.89 ADORA1 (0.47) MAPK1SMN1; SMN2NPC1ALDH1A1RAB9A
SCHEMBL12839084 0.88 ADORA1 (0.46) SMN1; SMN2NPC1ALDH1A1RAB9AMAPT
SCHEMBL1356482 0.88 APP (0.54) SMN1; SMN2NPC1ALDH1A1TP53RAB9A
SCHEMBL12839209 0.88 ADORA1 (0.46) SMN1; SMN2NPC1ALDH1A1RAB9AMAPT
SCHEMBL12840441 0.87 MAPT (0.47) MAPK1NPC1RAB9AMAPTPRKDC
SCHEMBL12838962 0.86 RAB9A (0.56) MAPK1SMN1; SMN2NPC1ALDH1A1TP53
SCHEMBL1354165 0.86 PRKDC (0.49) MAPK1SMN1; SMN2ALDH1A1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110070656-A1 Fluorescent Proteins JNC CORPORATION (JP) 2011-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110070656-A1 Fluorescent Proteins CACYBP, CHLSN, LCP2 MAPK1 4830/4885SMN1; SMN2 4784/4885NPC1 2936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.